Bracco
VC Fund
Milan, Italy
Bracco is a VC fund in Milan focused on Medical and Health Care. Bracco specializes in diagnostic imaging for the healthcare sector.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Bracco invests in
Stages Bracco invests in
Countries Bracco invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Clark
|
|||
Cornelia B. Reininger
|
|||
Diana Bracco
|
|||
Elio Bracco
|
|||
Kohei Endo
|
Investment Focus
Industry
- Medical 2 (67%)
- Health Care 2 (67%)
- Pharmaceutical 2 (67%)
- Therapeutics 1 (33%)
- Manufacturing 1 (33%)
Stage
- Series A 1 (33%)
- Post-IPO Equity 1 (33%)
Country
- United States 1 (33%)
- United Kingdom 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chris Clark
Senior Director Digital Operations
|
Senior Director Digital Operations | Total investments: 0 | Find email | |
|
Cornelia B. Reininger
Director, Medical Services, Planning and Management
|
Director, Medical Services, Planning and Management | Total investments: 0 | Find email | |
|
Diana Bracco
President and CEO; Founder, CEO & President
|
President and CEO; Founder, CEO & President | Total investments: 0 | Find email | |
|
Elio Bracco
Founder
|
Founder | Total investments: 0 | Find email | |
|
Kohei Endo
President & Representative Director
|
President & Representative Director | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Blue Earth Therapeutics
|
Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of next-generation targeted radiotherapeutics to treat cancer patients. It is a sister company of Blue Earth Diagnostics. | $76.5M / Series A / Oct 30, 2024 | |
|
Blue Earth Therapeutics
|
Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of next-generation targeted radiotherapeutics to treat cancer patients. It is a sister company of Blue Earth Diagnostics. | $76.5M / Series A / Oct 30, 2024 | |
Polarean
|
Polarean designs and manufactures equipment for the production of hyperpolarized xenon or helium gas. When used in conjunction with MRI, these gases offer a fundamentally new and non-invasive functional imaging platform. Current investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression andtherapeutic response. In addition, xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs.The company is pursuing regulatory approval for clinical use and also sells its hyperpolarizes and related equipment to academic research institutions worldwide. In addition to providing academic researchers with this equipment and support, Polarean Imaging plc. offers access to the intellectual property that provides freedom-to-operate in this technology area.Polarean was founded in 2011 and is headquartered in Durham, NC, USA. | $12.6M / Post-IPO Equity / May 22, 2024 |
Co-Investors
PBM Capital Group
2 deals together
Sands Capital Ventures
2 deals together
Soleus Capital
2 deals together
Woodline Partners
2 deals together
NUKEM Isotopes
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bracco invest in?
Bracco invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Series A and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bracco?
Public channels for Bracco include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bracco?
The team at Bracco includes Chris Clark (Senior Director Digital Operations), Cornelia B. Reininger (Director, Medical Services, Planning and Management) and Diana Bracco (President and CEO; Founder, CEO & President), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
